Showing results (1631-1640 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|September 15, 2015
Curtailed two-stage matched pairs design in double-arm Phase II clinical trialsChrista Carsten, Pinyuen ChenJournal of Biopharmaceutical Statistics|September 18, 2015
On sample size estimation and re-estimation adjusting for variability in confirmatory trialsPei-Shien Wu, Min Lin, Shein-Chung ChowJournal of Biopharmaceutical Statistics|September 19, 2017
Influence Analysis for the Area Under the Receiver Operating Characteristic CurveBo-Shiang Ke, An Jen Chiang, Yuan-Chin Ivan ChangJournal of Biopharmaceutical Statistics|August 30, 2017
Statistical inference following sample size adjustment based on the 50%-conditional-power principleY H Joshua Chen, Shuai S Yuan, Xiaoming LiJournal of Biopharmaceutical Statistics|September 1, 2017
Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation resultsRichard F PotthoffJournal of Biopharmaceutical Statistics|September 8, 2017
A HIERARCHICAL BINOMIAL-POISSON MODEL FOR THE ANALYSIS OF A CROSSOVER DESIGN FOR CORRELATED BINARY DATA WHEN THE NUMBER OF TRIALS IS DOSE-DEPENDENTZiv Shkedy, Geert Molenberghs, Hansfried Van Craenendonck, et al.Journal of Biopharmaceutical Statistics|September 9, 2017
A comparison of multiple imputation methods for incomplete longitudinal binary dataYusuke Yamaguchi, Toshihiro Misumi, Kazushi MaruoJournal of Biopharmaceutical Statistics|September 9, 2017
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design frameworkShogo Nomura, Akihiro Hirakawa, Chikuma HamadaJournal of Biopharmaceutical Statistics|September 14, 2017
Phase II cancer clinical trials for biomarker-guided treatmentsSin-Ho JungJournal of Biopharmaceutical Statistics|February 17, 2016
A new PK equivalence test for a bridging studySteven J Novick, Xiang Zhang, Harry YangPageof 216